RecallDepth
Class II Ongoing

Doxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-637-31

This recall is currently active, issued August 13, 2025. It was issued by Alembic Pharmaceuticals Limited.

Company
Alembic Pharmaceuticals Limited
Recall Initiated
July 25, 2025
Posted
August 13, 2025
Recall Number
D-0566-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
9,492 bottles
Firm Location
Panchmahal, India
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.

Distribution

Nationwide in the USA.

Lot / Code Info

Lot: 2305015142, Exp. Date: 9/30/2025

More recalls by Alembic Pharmaceuticals Limited

View all recalls by this company →

Other recent Class II Drug recalls